Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Emre Yekeduz, M.D.

Concepts (119)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Carcinoma, Renal Cell8202331641.560 Why?
Kidney Neoplasms8202342501.410 Why?
Turkey1020242531.170 Why?
Phenylurea Compounds220225290.790 Why?
Stomach Neoplasms2202214530.770 Why?
Oseltamivir12020750.680 Why?
Polypharmacy120222860.660 Why?
Azithromycin120201990.630 Why?
Antineoplastic Agents42022136350.600 Why?
Neoplasm Metastasis4202349100.580 Why?
Rectal Neoplasms2202211560.550 Why?
Neoplasms72022221310.540 Why?
Colonic Diseases120182010.540 Why?
Intestinal Perforation120182490.530 Why?
Incidental Findings120206970.490 Why?
Clinical Laboratory Techniques120207450.480 Why?
Scleroderma, Systemic120183440.460 Why?
Drug Approval120218120.460 Why?
Colorectal Neoplasms3202269250.460 Why?
Hyperglycemia1202213750.440 Why?
Prognosis112024296000.410 Why?
Coronavirus Infections2202030880.410 Why?
Colonic Neoplasms2202225330.400 Why?
Pneumonia, Viral2202032090.400 Why?
Lung Neoplasms32022133820.400 Why?
Immunotherapy3202246420.370 Why?
Molecular Targeted Therapy1202128120.350 Why?
Pyridines1202228740.340 Why?
Patient Selection1202142370.320 Why?
Antineoplastic Combined Chemotherapy Protocols52023117360.320 Why?
Clinical Trials, Phase III as Topic320248570.310 Why?
Lutetium22024380.290 Why?
Prostatic Neoplasms32024111060.260 Why?
Inflammation52024107600.260 Why?
Pandemics3202086450.260 Why?
Dipeptides220243910.250 Why?
Adenocarcinoma1202263400.240 Why?
Retrospective Studies152024805660.230 Why?
Diabetes Mellitus1202258350.220 Why?
Humans3620247606170.220 Why?
Androgen Antagonists2202314090.220 Why?
Castration120231510.220 Why?
Adrenocortical Carcinoma12024880.210 Why?
Kaplan-Meier Estimate3202464740.210 Why?
Lactate Dehydrogenases12022260.210 Why?
Adrenal Cortex Neoplasms120241610.200 Why?
Sarcoma, Synovial120231530.190 Why?
Lung1202099980.190 Why?
Melanoma1202056970.190 Why?
Phenylthiohydantoin120222050.180 Why?
Esophagogastric Junction120223470.170 Why?
Leiomyosarcoma120234220.160 Why?
Brain Neoplasms1202090260.150 Why?
Prednisone1202315620.150 Why?
Thromboembolism120249910.150 Why?
Proton Pump Inhibitors120225300.140 Why?
Prostate-Specific Antigen2202424650.140 Why?
Nitriles120229710.140 Why?
Benzamides1202213710.140 Why?
Immunocompromised Host120228580.130 Why?
Medical Records1202214070.130 Why?
Male1620243603580.130 Why?
Hydroxychloroquine120204260.130 Why?
Receptors, Androgen1202210790.130 Why?
Periodontal Diseases120194510.130 Why?
Neoplasm, Residual1202010080.130 Why?
HIV Infections12022173370.120 Why?
Neoplasms, Second Primary1202310510.120 Why?
Antineoplastic Agents, Hormonal1202315200.120 Why?
Aged1020241690420.120 Why?
Guidelines as Topic1202113860.120 Why?
Soft Tissue Neoplasms1202311580.110 Why?
Heterocyclic Compounds, 1-Ring22024680.110 Why?
Lymphocytes1202126040.110 Why?
Antiretroviral Therapy, Highly Active1202218940.110 Why?
Infection Control120209820.100 Why?
United States Food and Drug Administration1202116610.100 Why?
Chemotherapy, Adjuvant1202035140.100 Why?
Protein Kinase Inhibitors3202356720.100 Why?
Sarcoma1202318000.100 Why?
Female1220243921480.100 Why?
Survival Rate22022127190.090 Why?
Neoadjuvant Therapy1202228270.090 Why?
Disease Management1202125060.090 Why?
Glucose1202243450.090 Why?
Disease-Free Survival1202068070.090 Why?
Middle Aged1020242205840.090 Why?
Angiogenesis Inhibitors1202020480.080 Why?
Neutrophils1202137630.080 Why?
Evidence-Based Medicine1202136800.080 Why?
Treatment Outcome42024645680.080 Why?
Liver Neoplasms1202343080.070 Why?
Antiviral Agents1202030390.070 Why?
Tomography, X-Ray Computed22020205560.070 Why?
Databases, Factual1202179600.070 Why?
Early Detection of Cancer1202031960.060 Why?
Age Factors12022183810.060 Why?
Mass Screening1202054240.060 Why?
Cohort Studies32022414570.060 Why?
T-Lymphocytes12022101750.060 Why?
Histamine Antagonists12023920.050 Why?
Neoplasm Recurrence, Local1202192770.050 Why?
Radioisotopes120244990.050 Why?
United States22021722720.050 Why?
Anti-Bacterial Agents1202174020.050 Why?
Indazoles120233040.050 Why?
Risk Factors32024741150.040 Why?
Aged, 80 and over22024588940.040 Why?
Purines120226060.040 Why?
Young Adult22024591790.040 Why?
Aminopyridines120225730.040 Why?
Adolescent22024882340.030 Why?
Adult420242209690.030 Why?
Breast Neoplasms12022209880.030 Why?
Receptor, erbB-21202225530.020 Why?
Survival Analysis12024100730.020 Why?
Tumor Microenvironment1202338680.020 Why?
Disease Progression12023134950.020 Why?
Prospective Studies12023543600.010 Why?
Yekeduz's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (119)
Explore
_
Co-Authors (4)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.